Deficient Histone Acetylation in Acute Leukemia and the Correction by an Isothiocyanate

Abstract

Deficient histone acetylation may represent an aberration at the epigenetic level in acute leukemia. PHI might represent a target for correcting deficient acetylation, and potential epigenetic regulators for preventing the progression of leukemia.